Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such a disease means that the comorbidities associated with COPD should be taken into account in both diagnosis and treatment. First and foremost, cardiovascular comorbidities should be mentioned. In the advanced stage, osteoporosis and muscle hypotrophy are important comorbidities that should be addressed.
Autoren
- PD Dr. med. Sebastian Fähndrich
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Participation of the patient
Adherence in psychiatry
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Eosinophilic esophagitis
EoE rarely occurs in isolation
- Lung cancer with EGFR mutation
New perspectives in first-line therapy
- Sleep disorder
Sleep medicine in transition: new goals and a reassessment of old hypnotics
- Ginkgo biloba extract in the Alzheimer's mouse model
Effects on disease-associated microglia subpopulations
- "Patients W.A.I.T Indicator"
Access to medicines – how does Switzerland compare across Europe?
- Osteoporosis